Search Images Maps Play YouTube News Gmail Drive More »
Sign in
Screen reader users: click this link for accessible mode. Accessible mode has the same essential features but works better with your reader.


  1. Advanced Patent Search
Publication numberUS2671451 A
Publication typeGrant
Publication dateMar 9, 1954
Filing dateJun 16, 1952
Priority dateJun 16, 1952
Publication numberUS 2671451 A, US 2671451A, US-A-2671451, US2671451 A, US2671451A
InventorsBolger Stephen J
Original AssigneeBolger Stephen J
Export CitationBiBTeX, EndNote, RefMan
External Links: USPTO, USPTO Assignment, Espacenet
Remedial pill
US 2671451 A
Previous page
Next page
Description  (OCR text may contain errors)

5. J. BOLGER REMEDIAL PILL March 9, 1954 Filed June 16, 1952 INVENTOR fiephen' JLBO {9 mauw ATTORNEY Patented Mar. 9, 1954 UNITED STATES PATENT OFFICE 3 Claims.

The present invention relates to remedies and more particularly to pill-type remedies and a method of treating internal disorders.

In localized disorders of the alimentary canal, particularly ulcers, it is very diflicult to apply a remedy to the affected spot for the reason that there is a constant flow through the canal caused by the normal digestive processes. Any remedy in the form of a tablet or pill is therefore quickly washed past the affected spot and consequently has very little or no remedial efiect. There are known remedies which, if they could be made to stop at or near the affected spot, would slowly dissolve, with a highly beneficial effect.

The objects of this invention are, therefore, to provide an efiicacious method of treating such localized internal disorders, and more specifically to provide a special type of pill to be used in connection with the method.

Illustrative embodiments of the invention are shown in the accompanying drawing, wherein:

Figure 1 is a front view of a human torso showing parts of the alimentary canal in cutaway view;

Figure 2 is a similar view of a human torso showing parts of the alimentary canal in dotted lines and illustrating the first step in practicing my new method;

Figure 3 is a cutaway view of a part of the alimentary canal showing the esophagus, the stomach, the pylorus and the duodenum, which view illustrates another step in the practice of my new method;

Figure 4 is a central sectional view through a spherical pill made according to the invention; and

Figure 5 is a. perspective view of a lozenge or tablet form of the pill.

Referring now in detail to these drawings, Figures 1 and 2 show the human torso generally designated l and parts of the alimentary canal comprising the esophagus II, the stomach l2, and the intestines which are generally designated I3.

Any part of the alimentary canal might be locally affected as by an ulcer, and if so afiected could be treated according to my new method. However for the purpose oi illustration I have shown in Figure 3 the pylorus ll affected by an ulcer I 5.

In treating the ulcer according to my method, I first apply to the exterior of the human torso nearest the ulcer a powerful magnet l6 (see Figure 2) here shown as a bar magnet secured Cir in position as by means of adhesive tape II. It will be understood that any other form of magnet such as an electromagnet might be used in place of the magnet IB. Next I administer to the patient, who is preferably in a reclining position, a special pill generally designated 18 in Figure 3. This special pill forms a part of my invention, and comprises a body of the prescribed remedial substance having a, magnetically attractable metallic element associated therewith. The pill illustrated in Figure 4 is of spherical form, having a body 19 of the remedial substance and a spherical core 28 of iron or other magnetically attractable metal. The pill shown in Figure 5 is similar, comprising a lozenge-type body 2| of the remedial substance and a core 22 of magnetically attractable metal.

When the pill has passed through the alimentary canal to a point at or near the ulcer IE, it is halted in its passage by the magnet "S, whereupon the pill slowly dissolves in the immediate vicinity of the ulcer with beneficial efiects thereon. When the pill has completely dissolved the magnet IB is removed from the patient's body and the metallic core of the pill passes harmlessly therethrough.

While I have described but one application of my invention, and indicated others, it will be understood that the method and the form of pill might find numerous other applications falllng within the scope of the following claims.

I claim:

1. A remedial pill comprising a remedial substance which is soluble in the human body and a. magnetically attractable metallic element associated with said substance.

2. A remedial pill having a core of magnetically attractable metal encased in a remedial substance which is soluble in the human body.

3. A spherical remedial pill having a spherical core of magnetically attractable metal.


References Cited in the file of this patent UNITED STATES PATENTS Number Name Date 1,505,209 Leach et al Aug. 19, 1924 2,483,098 Millard Sept. 27, 1949 2,518,758 Cook Aug. 15, 1950 FOREIGN PATENTS Number Country Date 485,378 Great Britain May 18, 1938

Patent Citations
Cited PatentFiling datePublication dateApplicantTitle
US1505209 *May 12, 1922Aug 19, 1924Leach Albert ARadium-carrying device
US2483098 *Jan 9, 1946Sep 27, 1949Millard Everett LSupplying agents to the digestive tract
US2518758 *Jun 22, 1949Aug 15, 1950George B CookMagnetic stirring apparatus
GB485378A * Title not available
Referenced by
Citing PatentFiling datePublication dateApplicantTitle
US2863458 *Sep 4, 1957Dec 9, 1958Bambara John PVein stripper and a method of stripping veins
US2921584 *Dec 17, 1954Jan 19, 1960Honeywell Regulator CoVessel occluder
US2971916 *Jan 30, 1957Feb 14, 1961Ncr CoMicroscopic capsules containing magnetizable material
US3042616 *Aug 26, 1958Jul 3, 1962IbmProcess of preparing magnetic ink
US3056724 *Sep 24, 1958Oct 2, 1962Commw Scient Ind Res OrgTherapeutic pellets for ruminants
US3057344 *May 21, 1957Oct 9, 1962Alberto Abella CarlosCapsule for the study of the digestive tract and method of using the same
US3118439 *Mar 19, 1958Jan 21, 1964Jean-Pierre PerrenoudDiagnostic and medicating capsule and the method of use
US3146169 *Jun 8, 1962Aug 25, 1964Burroughs Wellcome CoPharmaceutical formulations and their manufacture
US3421210 *Aug 2, 1965Jan 14, 1969Nitroglycerin AbMethod for the manufacture of the fuse head element of electric fuses
US3474777 *Feb 10, 1966Oct 28, 1969Amp IncMethod of administering therapeutic agents
US3592185 *Apr 18, 1967Jul 13, 1971Yeda Res & DevFerromagnetic contrast media and method of use
US3608549 *Jan 15, 1970Sep 28, 1971Merrill Edward WilsonMethod of administering drugs and capsule therefor
US4030499 *Jun 7, 1976Jun 21, 1977Louis BucaloMethod and apparatus for providing living beings with absorbable implants
US4162679 *Sep 28, 1977Jul 31, 1979Reenstierna Erik G BMethod and device for the implantation of one or more pacemaker electrodes in a heart
US4247406 *Apr 23, 1979Jan 27, 1981Widder Kenneth JIntravascularly-administrable, magnetically-localizable biodegradable carrier
US4331654 *Jun 13, 1980May 25, 1982Eli Lilly And CompanyDrug carrier formulation
US4830855 *Nov 13, 1987May 16, 1989Landec Labs, Inc.Temperature-controlled active agent dispenser
US4878905 *Aug 10, 1988Nov 7, 1989Blass Karl GGastrointestinal module: a nonsurgical implant
US5079006 *Jul 13, 1988Jan 7, 1992Aprex CorporationPharmaceutical compositions containing a magnetically detectable material
US5162037 *May 7, 1991Nov 10, 1992Whitson Laboratories, Inc.Magnetically influenced homeopathic pharmaceutical formulations, methods of their preparation and methods of their administration
US5401516 *Apr 22, 1993Mar 28, 1995Emisphere Technologies, Inc.Encapsulation of biologically active materials, drug delivery, reaction with benzenesulfonyl chloride or benzoyl chloride
US5443841 *Jul 27, 1992Aug 22, 1995Emisphere Technologies, Inc.Proteinoid microspheres and methods for preparation and use thereof
US5447728 *Dec 16, 1993Sep 5, 1995Emisphere Technologies, Inc.A carrier comprising an acylated amino acid; lowering iron concentration in mammals
US5529568 *Mar 18, 1994Jun 25, 1996Surgery Futures Research, Inc.Magnetic operating table
US5540939 *Apr 25, 1994Jul 30, 1996Emisphere Technologies, Inc.Encapsulating active materials
US5541155 *Apr 22, 1994Jul 30, 1996Emisphere Technologies, Inc.Acids and acid salts and their use in delivery systems
US5578323 *Jun 14, 1993Nov 26, 1996Emisphere Technologies, Inc.Proteinoid carriers and methods for preparation and use thereof
US5593379 *Jun 5, 1995Jan 14, 1997Surgery Futures Research, Inc.For carrying out laparoscopic surgery of an intestine
US5601846 *May 9, 1995Feb 11, 1997Emisphere Technologies, Inc.Oligopeptide
US5629020 *Apr 22, 1994May 13, 1997Emisphere Technologies, Inc.Delivery of sensitive agents such as bioactive peptides
US5643957 *Oct 25, 1994Jul 1, 1997Emisphere Technologies, Inc.Compounds and compositions for delivering active agents
US5650386 *Mar 31, 1995Jul 22, 1997Emisphere Technologies, Inc.Compositions for oral delivery of active agents
US5667806 *Jun 7, 1995Sep 16, 1997Emisphere Technologies, Inc.Spray drying method and apparatus
US5693338 *Sep 29, 1994Dec 2, 1997Emisphere Technologies, Inc.Delivery composition comprising active agent, diketopiperazine, enzyme inhibitor
US5709861 *Jan 13, 1995Jan 20, 1998Emisphere Technologies, Inc.Compositions for the delivery of antigens
US5714167 *Oct 25, 1994Feb 3, 1998Emisphere Technologies, Inc.Reversibly forming supramolecular complex of active agent with perturbant; drug delivery
US5750147 *Jun 7, 1995May 12, 1998Emisphere Technologies, Inc.Fungicides for oral administration
US5766633 *Apr 22, 1994Jun 16, 1998Emisphere Technologies, Inc.Modified amino acid carrier, bioactive peptides
US5792451 *Mar 2, 1994Aug 11, 1998Emisphere Technologies, Inc.Oral drug delivery compositions and methods
US5804688 *Feb 7, 1997Sep 8, 1998Emisphere Technologies, Inc.Compounds and compositions for delivering active agents
US5811127 *Oct 24, 1994Sep 22, 1998Emisphere Technologies, Inc.Desferrioxamine oral delivery system
US5820881 *Apr 28, 1995Oct 13, 1998Emisphere Technologies, Inc.Microspheres of diamide-dicarboxylic acids
US5824345 *Jun 7, 1995Oct 20, 1998Emisphere Technologies, Inc.Microsphere comprising active agent, proteinoid, modified hydrolyzed vegetable protein
US5840340 *Aug 30, 1996Nov 24, 1998Emisphere Technologies, Inc.Oligopeptides with fragrance, cosmetics and dye
US5863944 *Apr 30, 1997Jan 26, 1999Emisphere Technologies, Inc.Compounds and compositions for delivering active agents
US5866536 *Feb 6, 1997Feb 2, 1999Emisphere Technologies, Inc.Compounds and compositions for delivering active agents
US5876710 *Feb 7, 1997Mar 2, 1999Emisphere Technologies Inc.Drug delivery; using a brominated benzamide compound
US5879681 *Feb 7, 1997Mar 9, 1999Emisphere Technolgies Inc.Compounds and compositions for delivering active agents
US5939381 *Feb 7, 1997Aug 17, 1999Emisphere Technologies, Inc.4-(4-(phenoxyacetyl)aminophenyl)butyric acid as a carrier for drug delivery
US5955503 *Feb 6, 1997Sep 21, 1999Emisphere Technologies, Inc.Modified amino acid compounds useful as carriers in the delivery of biologically active agents such as, for example, bioactive peptides and the like
US5958457 *May 10, 1995Sep 28, 1999Emisphere Technologies, Inc.Compositions for the delivery of antigens
US5962710 *May 9, 1997Oct 5, 1999Emisphere Technologies, Inc.Reacting an oligosalicylate and an amino acid
US5965121 *Feb 6, 1997Oct 12, 1999Emisphere Technologies, Inc.Compounds and compositions for delivering active agents
US5972387 *Nov 21, 1994Oct 26, 1999Emisphere Technologies, Inc.Modified hydrolyzed vegetable protein microspheres and methods for preparation and use thereof
US5976569 *Apr 29, 1997Nov 2, 1999Emisphere Technologies, Inc.Diketopiperazine-based delivery systems
US5989539 *Feb 6, 1997Nov 23, 1999Emisphere Technologies, Inc.Compounds and compositions for delivering active agents
US5990166 *Feb 7, 1997Nov 23, 1999Emisphere Technologies, Inc.Compounds and compositions for delivering active agents
US6001347 *Feb 6, 1997Dec 14, 1999Emisphere Technologies, Inc.Organic acid compound of given structure having an aromatic amide group, a methoxy group in the ortho position on the aromatic ring, and a lipophilic chain terminated with a carboxylic acid is useful as a nontoxic carrier
US6051258 *Jun 7, 1995Apr 18, 2000Emisphere Technologies, Inc.Proteinoid emulsions and methods for preparation and use thereof
US6060513 *Feb 7, 1997May 9, 2000Emisphere Technologies, Inc.Compounds and compositions for delivering active agents
US6071510 *Apr 23, 1997Jun 6, 2000Emisphere Technologies, Inc.Modified amino acids and compositions comprising the same for delivering active agents
US6071538 *Sep 30, 1997Jun 6, 2000Emisphere Technologies, Inc.Oral delivery composition comprising supramolecular complex
US6084112 *Sep 10, 1996Jul 4, 2000Emisphere Technologies, Inc.Method for preparing ω-aminoalkanoic acid derivatives from cycloalkanones
US6090958 *Feb 7, 1997Jul 18, 2000Emisphere Technologies, Inc.N-(8-carboxyoctyl)-o-hydroxybenzamide and salts
US6099856 *Dec 10, 1996Aug 8, 2000Emisphere Technologies, Inc.Increased bioavailable
US6100285 *Nov 11, 1997Aug 8, 2000Emisphere Technologies, Inc.Method of solubilizing itraconazole
US6100298 *Feb 6, 1997Aug 8, 2000Emisphere Technologies, Inc.Mixture of drug and n-(4-(carboxypropyl)phenyl-4-phenyl-butyramide for improved oral drug delivery
US6180140Jun 2, 1995Jan 30, 2001Emisphere Technologies, Inc.Modified amino acids for drug delivery
US6221367Sep 29, 1997Apr 24, 2001Emisphere Technologies, Inc.Exposing a biologically active agent to a complexing perturbant to reversibly transform the biologically active agent to the intermediate state and to form a transportable supramolecular complex
US6242495Jun 16, 2000Jun 5, 2001Emisphere Technologies, Inc.Compounds and compositions for delivering active agents
US6245359Sep 30, 1997Jun 12, 2001Emisphere Technologies, Inc.Active agent transport systems
US6313088Feb 7, 1997Nov 6, 2001Emisphere Technologies, Inc.Carriers used to deliver various active agents through various biological, chemical, and physical barriers
US6331318Sep 30, 1994Dec 18, 2001Emisphere Technologies Inc.Carbon-substituted diketopiperazine delivery systems
US6346242Feb 8, 2000Feb 12, 2002Emishpere Technologies, Inc.Compounds and compositions for delivering active agents
US6348207Sep 30, 1997Feb 19, 2002Emisiphere Technologies, Inc.Exposing biologically active agent to complexing perturbant to reversibly transform biologically active agent to intermediate state and form orally deliverable supramolecular complex, orally administering complex to subject
US6375983Jun 12, 1997Apr 23, 2002Emisphere Technologies, Inc.Microencapsulated fragrances and method for preparation
US6413550Nov 23, 1998Jul 2, 2002Emisphere Technologies, Inc.Proteinoid carriers and methods for preparation and use thereof
US6428780May 5, 1999Aug 6, 2002Emisphere Technologies, Inc.Modified amino acid
US6461545Jan 6, 2000Oct 8, 2002Emisphere Technologies, Inc.Method of solubilizing and encapsulating itraconazole
US7417022Apr 11, 2005Aug 26, 2008Mhr Institutional Partners Iia LpAmino acid for deliverying active materials; bioavailability
US7553872Feb 13, 2006Jun 30, 2009Emisphere Technologies, Inc.Compounds and compositions for delivering active agents
US8686154Jun 10, 2009Apr 1, 2014Emisphere Technologies, Inc.Compounds and compositions for delivering active agents
USRE35862 *Aug 14, 1987Jul 28, 1998Emisphere Technologies, Inc.Delivery systems for pharmacological agents encapsulated with proteinoids
EP0000667A1 *Jul 28, 1978Feb 7, 1979Northwestern UniversityIntravascularly-administrable, magnetically-localizable biodegradable carrier and process for its preparation
EP0042249A2Jun 10, 1981Dec 23, 1981Northwestern UniversityMagnetically-localizable, biodegradable lipid microspheres
EP0409893A1 *Apr 3, 1989Jan 30, 1991FISCHMAN, Walter WhitsonMagnetically influenced homeopathic pharmaceutical formulations and methods of their preparation
EP0773005A1Nov 13, 1995May 14, 1997Surgery Futures Research Inc.Magnetic operation table
U.S. Classification604/288, 600/12, 252/62.55, 335/285, 604/57
International ClassificationA61K9/50
Cooperative ClassificationA61K9/5094
European ClassificationA61K9/50T